Delia Cangini

2.6k total citations
32 papers, 1.7k citations indexed

About

Delia Cangini is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Delia Cangini has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 19 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Delia Cangini's work include Multiple Myeloma Research and Treatments (20 papers), Cancer Treatment and Pharmacology (10 papers) and Protein Degradation and Inhibitors (7 papers). Delia Cangini is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Cancer Treatment and Pharmacology (10 papers) and Protein Degradation and Inhibitors (7 papers). Delia Cangini collaborates with scholars based in Italy, United States and India. Delia Cangini's co-authors include Elena Zamagni, Michèle Cavo, Patrizia Tosi, Michele Baccarani, Paola Tacchetti, S Tura, Claudia Cellini, Antonio De Vivo, Giulia Perrone and Michela Ceccolini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Delia Cangini

29 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Delia Cangini 1.4k 960 922 203 84 32 1.7k
Dimitrios Christoulas 1.2k 0.8× 642 0.7× 600 0.7× 608 3.0× 66 0.8× 89 1.6k
Miguel‐Teodoro Hernández 796 0.6× 544 0.6× 597 0.6× 210 1.0× 21 0.3× 44 1.2k
Claudia Cellini 1.2k 0.8× 813 0.8× 862 0.9× 271 1.3× 19 0.2× 30 1.6k
Parameswaran Venugopal 1.1k 0.7× 412 0.4× 684 0.7× 482 2.4× 131 1.6× 130 1.9k
Silvia Mangiacavalli 954 0.7× 677 0.7× 548 0.6× 499 2.5× 32 0.4× 56 1.5k
D A Gastineau 1.1k 0.8× 473 0.5× 478 0.5× 264 1.3× 17 0.2× 35 1.5k
Antonietta Falcone 1.5k 1.0× 648 0.7× 945 1.0× 500 2.5× 37 0.4× 60 1.7k
Anne Marie Stoppa 844 0.6× 322 0.3× 555 0.6× 196 1.0× 26 0.3× 43 1.2k
Maro Ohanian 1.2k 0.9× 306 0.3× 678 0.7× 528 2.6× 51 0.6× 120 1.8k
Jamile M. Shammo 874 0.6× 305 0.3× 429 0.5× 587 2.9× 56 0.7× 79 1.5k

Countries citing papers authored by Delia Cangini

Since Specialization
Citations

This map shows the geographic impact of Delia Cangini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delia Cangini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delia Cangini more than expected).

Fields of papers citing papers by Delia Cangini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delia Cangini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delia Cangini. The network helps show where Delia Cangini may publish in the future.

Co-authorship network of co-authors of Delia Cangini

This figure shows the co-authorship network connecting the top 25 collaborators of Delia Cangini. A scholar is included among the top collaborators of Delia Cangini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delia Cangini. Delia Cangini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Servili, Chiara, Emanuela Scarpi, Delia Cangini, et al.. (2024). Combining Gene Expression Profiling and Integrated Multidisciplinary Approaches to Improve Prognosis Prediction in Multiple Myeloma. Blood. 144(Supplement 1). 6838–6838.
2.
Ferrari, Anna, Delia Cangini, Andrea Ghelli Luserna di Rorà, et al.. (2023). Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations. Frontiers in Cell and Developmental Biology. 11. 1165308–1165308. 1 indexed citations
3.
4.
Cerchione, Claudio, Giovanni Martinelli, Marco Picardi, et al.. (2020). Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial. Journal of Clinical Medicine. 9(2). 395–395. 6 indexed citations
5.
Cangini, Delia, Carla Masini, Andrea Ghelli Luserna di Rorà, et al.. (2020). Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope. Minerva Medica. 111(5). 467–477. 9 indexed citations
6.
Gottardi, Michele, Alessandra Sperotto, Andrea Ghelli Luserna di Rorà, et al.. (2020). Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future. Minerva Medica. 111(5). 395–410. 11 indexed citations
7.
Ridolfi, Laura, Delia Cangini, Riccardo Galassi, et al.. (2008). Reversible, PET-positive, Generalized Lymphadenopathy and Splenomegaly During High-dose Interferon-α-2b Adjuvant Therapy for Melanoma. Journal of Immunotherapy. 31(7). 675–678. 5 indexed citations
8.
9.
Cavo, Michèle, Patrizia Tosi, Elena Zamagni, et al.. (2007). Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study. Journal of Clinical Oncology. 25(17). 2434–2441. 248 indexed citations
10.
Nanni, Cristina, Elena Zamagni, Mohsen Farsad, et al.. (2006). Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging. 33(5). 525–531. 100 indexed citations
11.
Tosi, Patrizia, Elena Zamagni, Claudia Cellini, et al.. (2006). First‐line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. European Journal Of Haematology. 76(5). 399–404. 42 indexed citations
12.
Tosi, Patrizia, Elena Zamagni, Claudia Cellini, et al.. (2005). Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma. European Journal Of Haematology. 74(3). 212–216. 74 indexed citations
13.
14.
Cavo, Michèle, Elena Zamagni, Patrizia Tosi, et al.. (2004). First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 89(7). 826–31. 146 indexed citations
15.
Tosi, Patrizia, Elena Zamagni, Claudia Cellini, et al.. (2004). Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. European Journal Of Haematology. 73(2). 98–103. 89 indexed citations
16.
Cavo, Michèle, Paola Tacchetti, Elena Zamagni, et al.. (2004). Superiority of First-Line Thalidomide-Dexamethasone over Vincristine-Doxorubicin-Dexamethasone in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.. Blood. 104(11). 1489–1489. 12 indexed citations
17.
Tosi, P., Elena Zamagni, Claudia Cellini, et al.. (2002). Salvage Therapy With Thalidomide In Patients With Advanced Relapsed/Refractory Multiple Myeloma. Journal of the Peripheral Nervous System. 7(3). 209–209. 8 indexed citations
18.
Tosi, Patrizia, Sonia Ronconi, Elena Zamagni, et al.. (2001). Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.. PubMed. 86(4). 409–13. 26 indexed citations
19.
Cangini, Delia, et al.. (1996). Control of body temperature during abdominal aortic surgery. Acta Anaesthesiologica Scandinavica. 40(2). 187–190. 6 indexed citations
20.
Grillone, G, et al.. (1991). [Antibiotic prophylaxis in pediatric surgery].. PubMed. 57(11). 1181–2.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios Christoulas Breakdown of academic impact, for papers by Miguel‐Teodoro Hernández Breakdown of academic impact, for papers by Claudia Cellini Breakdown of academic impact, for papers by Parameswaran Venugopal Breakdown of academic impact, for papers by Silvia Mangiacavalli Breakdown of academic impact, for papers by D A Gastineau Breakdown of academic impact, for papers by Antonietta Falcone Breakdown of academic impact, for papers by Anne Marie Stoppa Breakdown of academic impact, for papers by Maro Ohanian Breakdown of academic impact, for papers by Jamile M. Shammo
Rankless by CCL
2026